1
项与 Murine CART19(University of Pennsylvania) 相关的临床试验CD19-Directed Chimeric Antigen Receptor CD19 Redirected Autologous T Cells (CART19) for Orphan Indications of Pediatric B Cell Acute Lymphoblastic Leukemia (B ALL)
This is an open-label, four-cohort, phase 2 study to determine the efficacy of CART19 in pediatric and young adult patientswith hypodiploid (Cohort A) or t(17;19) B-ALL (Cohort B), infants with very high risk KMT2A B-ALL (Cohort C), and in patients with central nervous system (CNS) relapse who did not receive cranial radiation (XRT) or bone marrow transplantation (BMT) (Cohort D).
100 项与 Murine CART19(University of Pennsylvania) 相关的临床结果
100 项与 Murine CART19(University of Pennsylvania) 相关的转化医学
100 项与 Murine CART19(University of Pennsylvania) 相关的专利(医药)
100 项与 Murine CART19(University of Pennsylvania) 相关的药物交易